<DOC>
	<DOCNO>NCT02613286</DOCNO>
	<brief_summary>This study open-label , multicenter , randomize , phase II non-inferiority trial ( proof concept study ) . Its purpose evaluate safety efficacy extrafascial hysterectomy plus pelvic-lymph node dissection compare standard modify radical hysterectomy patient stage IA2-IB1 cervical cancer ≤ 2cm .</brief_summary>
	<brief_title>LESs Surgical Radicality EaRly Stage Cervical Cancer</brief_title>
	<detailed_description>The purpose study evaluate safety efficacy extrafascial hysterectomy compare modified radical hysterectomy , plus level 1 pelvic lymph-node dissection , patient early stage IA2-IB1 cervical cancer ≤ 2cm . The experimental procedure consider promising treatment stage IA2-IB1 cervical cancer ≤ 2cm Bayesian posterior probability `` difference 3-y DFS rate less non-inferiority margin 5 % '' least 50 % . Thus , use proof concept design , plan sample size 40 , 20 case per arm , provide 72 % chance satisfy criterion , hypothesis low 3-y DFS rate arm 90 % . As require , adjuvant therapy include cisplatin-based chemo-radiation pelvic radiation alone ( EBRT +/- intracavitary brachytherapy ) indicate accord # GOG92 # GOG109 criterion .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<criteria>1 . Patients histologically confirm adenocarcinoma , squamous , adenosquamous cancer cervix LEEP , cone cervical biopsy ; 2 . Aged 18 70 year ; 3. performance status 02 ( ECOG , Eastern Cooperative Oncology Group ) / great 70 point Karnofsky scale ; 4 . FIGO early stage IA2IB1 ≤ 2cm ; 5 . Appropriated cardiorespiratory , hepatorenal hematological reserve ; 6 . Signing Consent Form . 1 . Limiting systemic comorbidities include neuropsychiatric disorder obesity ; 2 . Apparent confirm uncontrolled infection ; 3 . Other malignancy activity ; 4 . Previous radiation chemotherapy treatment major pelvic surgery ; 5 . History drug allergy , pregnancy breast feeding ; 6 . Evidence extensive disease time surgery .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>